首页> 外文期刊>Radiation oncology >Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer
【24h】

Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer

机译:比较动态强度调制放射疗法(dIMRT)与3D立体适形放射疗法(3DCRT)在高危前列腺癌的超分割治疗中的两种策略

获取原文
           

摘要

Background To compare two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the setting of hypofractionated high-risk prostate cancer treatment. Methods 3DCRT and dIMRT/Helical Tomotherapy(HT) planning with 10 CT datasets was undertaken to deliver 68 Gy in 25 fractions (prostate) and simultaneously delivering 45 Gy in 25 fractions (pelvic lymph node targets) in a single phase. The paradigms of pelvic vessel targeting (iliac vessels with margin are used to target pelvic nodes) and conformal normal tissue avoidance (treated soft tissues of the pelvis while limiting dose to identified pelvic critical structures) were assessed compared to 3DCRT controls. Both dIMRT/HT and 3DCRT solutions were compared to each other using repeated measures ANOVA and post-hoc paired t-tests. Results When compared to conformal pelvic vessel targeting, conformal normal tissue avoidance delivered more homogenous PTV delivery (2/2 t-test comparisons; p < 0.001), similar nodal coverage (8/8 t-test comparisons; p = ns), higher and more homogenous pelvic tissue dose (6/6 t-test comparisons; p < 0.03), at the cost of slightly higher critical structure dose (Ddose, 1–3 Gy over 5/10 dose points; p < 0.03). The dIMRT/HT approaches were superior to 3DCRT in sparing organs at risk (22/24 t-test comparisons; p < 0.05). Conclusion dIMRT/HT nodal and pelvic targeting is superior to 3DCRT in dose delivery and critical structure sparing in the setting of hypofractionation for high-risk prostate cancer. The pelvic targeting paradigm is a potential solution to deliver highly conformal pelvic radiation treatment in the setting of nodal location uncertainty in prostate cancer and other pelvic malignancies.
机译:背景为了比较动态低强度高危前列腺癌治疗中动态强度调制放射治疗(dIMRT)与3D立体适形放射治疗(3DCRT)的两种策略。方法采用10个CT数据集进行3DCRT和dIMRT / Helical Tomotherapy(HT)计划,以25个分数(前列腺)递送68 Gy,同时以25个分数(盆腔淋巴结靶点)递送45 Gy。与3DCRT对照相比,评估了骨盆血管靶向的范式(具有边缘的ilia骨血管靶向骨盆结)和避免了保形的正常组织(骨盆的软组织同时将剂量限制在已确定的骨盆关键结构上)。使用重复测量方差分析和事后配对t检验对dIMRT / HT和3DCRT解决方案进行了比较。结果与靶向保形盆腔血管相比,避免保形正常组织可实现更均匀的PTV递送(2/2 t-检验比较; p <0.001),相似的淋巴结覆盖率(8/8 t-检验比较; p = ns),更高骨盆组织剂量更高(6/6 t-test比较; p <0.03),但临界结构剂量略高(Ddose,在5/10个剂量点上为1-3 Gy; p <0.03)。在保留有风险的器官方面,dIMRT / HT方法优于3DCRT(22/24 t检验比较; p <0.05)。结论dIMRT / HT淋巴结和骨盆靶向在高风险前列腺癌的超分割情况下在剂量输送和关键结构保留方面优于3DCRT。骨盆靶向范例是在前列腺癌和其他骨盆恶性淋巴结位置不确定的情况下提供高度保形的骨盆放射治疗的潜在解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号